<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Premalignant <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> (BO) and gastric <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (IM) show <z:hpo ids='HP_0003812'>phenotypic variability</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Incompletely differentiated sulfomucin rich gastric IM (type III) may have increased malignant potential </plain></SENT>
<SENT sid="2" pm="."><plain>The types of sulfated <z:chebi fb="2" ids="50699">oligosaccharide</z:chebi> structures present in IM, BO, and colon have not been fully characterised </plain></SENT>
<SENT sid="3" pm="."><plain>AIMS: To compare <z:chebi fb="0" ids="29922">sulfo</z:chebi>-Lewis(a) <z:chebi fb="0" ids="53000">epitope</z:chebi> tissue distribution with high iron <z:chebi fb="3" ids="15571,23666">diamine</z:chebi> (HID) positive sulfomucin in metaplastic, dysplastic, and neoplastic tissues from oesophagus and stomach </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Sections containing gastric IM or BO (some associated with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>) were stained by the HID/alcian blue (AB) method and immunohistochemically (antibody 91.9H) to detect <z:chebi fb="0" ids="29922">sulfo</z:chebi>-Lewis(a) </plain></SENT>
<SENT sid="5" pm="."><plain>Based on HID/AB staining, IM was subtyped into type I (complete) or types II and III (incomplete) </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In total, 125 sections from 38 subjects were studied </plain></SENT>
<SENT sid="7" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath> squamous oesophagus, <z:mpath ids='MPATH_458'>normal</z:mpath> gastric epithelium, and type I IM were negative for sulfomucin and <z:chebi fb="0" ids="29922">sulfo</z:chebi>-Lewis(a) </plain></SENT>
<SENT sid="8" pm="."><plain>In type II IM, occasional goblet cells were HID and <z:chebi fb="0" ids="29922">sulfo</z:chebi>-Lewis(a) positive, but sialomucin secreting (AB positive) columnar cells were <z:chebi fb="0" ids="29922">sulfo</z:chebi>-Lewis(a) negative </plain></SENT>
<SENT sid="9" pm="."><plain>Type III IM was always <z:chebi fb="0" ids="29922">sulfo</z:chebi>-Lewis(a) positive </plain></SENT>
<SENT sid="10" pm="."><plain>Sulfomucin staining in <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was variable, but HID positive areas were always <z:chebi fb="0" ids="29922">sulfo</z:chebi>-Lewis(a) positive </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="29922">Sulfo</z:chebi>-Le(a), which is expressed on colonic mucin, is invariably present on sulfomucins in gastric IM and BO </plain></SENT>
<SENT sid="12" pm="."><plain>Its presence in incomplete variants of IM and its absence from type I IM emphasises the phenotypic differences between complete and incomplete forms of <z:mpath ids='MPATH_160'>metaplasia</z:mpath> </plain></SENT>
<SENT sid="13" pm="."><plain>91.9H immunostaining is useful in IM subtyping </plain></SENT>
<SENT sid="14" pm="."><plain>Characterising the molecular basis of <z:chebi fb="0" ids="29922">sulfo</z:chebi>-Lewis(a) expression may help understand the process of aberrant differentiation </plain></SENT>
</text></document>